sufentanil has been researched along with dihydromorphine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Gommeren, W; Leysen, JE | 1 |
3 other study(ies) available for sufentanil and dihydromorphine
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
In vitro binding properties of 3H-sufentanil, a superior ligand for the mu-opiate receptor.
Topics: Analgesics, Opioid; Animals; Brain; Dihydromorphine; Fentanyl; In Vitro Techniques; Kinetics; Membranes; Naloxone; Rats; Receptors, Opioid; Receptors, Opioid, mu; Spinal Cord; Stereoisomerism; Sufentanil | 1982 |